All industry news
RegulationSeptember 11, 2026

Nutromics Nabs FDA Breakthrough Status for Antibiotic Monitoring Patch

Nutromics received FDA breakthrough device designation for a wearable patch that monitors vancomycin levels in real time, intended to eliminate periodic blood draws for antibiotic dosing. The designation accelerates the regulatory pathway for the continuous monitoring technology.

The source

This brief is a MedIndexer summary of reporting by MedCity News. To read the full story, head to the source.

Read the full story at MedCity News
MedIndexer aggregates and summarises publicly available headlines. Full article text remains the property of the originating publication.